Clinical Trial Update: Lupus Atherosclerosis Prevention Study [Phase 4]

View source ↗

Summary

The Lupus Atherosclerosis Prevention Study, a Phase 4 clinical trial in systemic lupus erythematosus, has completed. Sponsor: Johns Hopkins University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Johns Hopkins University | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED